TP53BP2 and breast cancer: These results are in line with our previous study, which demonstrated that GNR (A) significantly upregulated the expression of TP53BP2 in the MCF-7 breast cancer cell line and modulated the expression of other regulatory genes involved in several apoptotic pathways [25].